scholarly journals Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME)

2014 ◽  
Vol 171 (6) ◽  
pp. 1318-1325 ◽  
Author(s):  
J.R. Chalmers ◽  
J. Schmitt ◽  
C. Apfelbacher ◽  
M. Dohil ◽  
L.F. Eichenfield ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Outcome Measures ◽  
Atopic Eczema ◽  
Consensus Meeting ◽  
Core Outcome ◽  
International Consensus ◽  
The Third ◽  
Core Outcome Measures

Core outcome measures for chronic pain clinical trials: IMMPACT recommendations

Pain ◽  
2005 ◽  
Vol 113 (1) ◽  
pp. 9-19 ◽  
Author(s):  
Robert H. Dworkin ◽  
Dennis C. Turk ◽  
John T. Farrar ◽  
Jennifer A. Haythornthwaite ◽  
Mark P. Jensen ◽  
...  
Keyword(s):  
Chronic Pain ◽  
Clinical Trials ◽  
Outcome Measures ◽  
Core Outcome ◽  
Core Outcome Measures

scholarly journals Consensus Building in OMERACT: Recommendations for Use of the Delphi for Core Outcome Set Development

2019 ◽  
Vol 46 (8) ◽  
pp. 1041-1046 ◽  
Author(s):  
Susan Humphrey-Murto ◽  
Richard Crew ◽  
Beverley Shea ◽  
Susan J. Bartlett ◽  
Lyn March ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Outcome Measures ◽  
Core Outcome Set ◽  
Delphi Process ◽  
Consensus Building ◽  
Core Outcome ◽  
Delphi Consensus ◽  
International Consensus ◽  
Work In Progress ◽  
Outcome Set

Objective.Developing international consensus on outcome measures for clinical trials is challenging. The following paper will review consensus building in Outcome Measures in Rheumatology (OMERACT), with a focus on the Delphi.Methods.Based on the literature and feedback from delegates at OMERACT 2018, a set of recommendations is provided in the form of the OMERACT Delphi Consensus Checklist.Results.The OMERACT delegates generally supported the use of the checklist as a guide. The checklist provides guidance for clearly outlining the multiple aspects of the Delphi process.Conclusion.OMERACT is deeply committed to consensus building and these recommendations should be considered a work in progress.

Automated Generation of Core Outcome Measures for Clinical Trials

2021 ◽  
Author(s):  
Anas Elghafari ◽  
Joseph Finkelstein
Keyword(s):  
Clinical Trials ◽  
Outcome Measures ◽  
Acute Coronary Syndromes ◽  
Core Outcome ◽  
Automated Generation ◽  
Coronary Syndromes ◽  
Core Outcome Measures ◽  
Automated Pipeline ◽  
Artery Disease ◽  
Clinical Trial Results

Common outcome sets are vital for ensuring usability of clinical trial results and enabling inter-study comparisons. The task of identifying clinical outcomes for a particular field is cumbersome and time-consuming. The aim of this work was to develop an automated pipeline for identifying common outcomes by analyzing outcomes from relevant trials reported at ClinicalTrials.gov and to assess the pipeline accuracy. We validated the output of our pipeline by comparing the outcomes it identified for acute coronary syndromes and coronary artery disease with the set of outcomes recommended for these conditions by a panel of experts in a widely cited report. We found that our pipeline identified the same or similar outcomes for 100% of the outcomes recommended in the experts’ report. The coverage of the pipeline’s results dropped only slightly (to 21 out of 23 outcome domains, 91%) when we restricted the pipeline to trials posted before the publication of the report, indicating a great potential for this pipeline to be used in aiding and informing the future development of core outcome measures in clinical trials.

scholarly journals Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations

Pain ◽  
2012 ◽  
Vol 153 (12) ◽  
pp. 2315-2324 ◽  
Author(s):  
Sandra D. Comer ◽  
James P. Zacny ◽  
Robert H. Dworkin ◽  
Dennis C. Turk ◽  
George E. Bigelow ◽  
...  
Keyword(s):  
Outcome Measures ◽  
Abuse Liability ◽  
Opioid Abuse ◽  
Core Outcome ◽  
Laboratory Assessment ◽  
Core Outcome Measures
Sign in / Sign up

Export Citation Format

Share Document